Lercanidipine hydrochloride is a third-generation dihydropyridine calcium channel blocker used clinically to manage hypertension by promoting the relaxation of vascular smooth muscle. Analytical laboratories… Read more



Lercanidipine hydrochloride is a third-generation dihydropyridine calcium channel blocker used clinically to manage hypertension by promoting the relaxation of vascular smooth muscle. Analytical laboratories rely on high-quality reference standards of the parent active pharmaceutical ingredient, alongside its related pharmacopeial and non-pharmacopeial impurities, to ensure precision in drug development and manufacturing. This category encompasses a comprehensive selection of these critical compounds, including synthetic impurities, degradation products, and metabolites. Pharmaceutical scientists utilize these reference materials for rigorous impurity profiling, method validation, and quality control of lercanidipine formulations. Additionally, stable isotope labelled compounds are available to serve as internal standards in mass spectrometry-based assays, facilitating accurate quantification and pharmacokinetic studies. By integrating these specialized reagents into testing protocols, laboratories can maintain regulatory compliance and verify the purity and stability of their pharmaceutical products throughout the drug lifecycle.